Immunoassay Market to exceed US$ 28.61 Bn by 2026
The global immunoassay market is expanding at a rapid pace due to high prevalence and rise in incidence of chronic, acute, and infectious diseases across the globe. The market was valued at US$ 16.54 Bn in 2017 and is projected to expand at a CAGR of 6.2% from 2018 to 2026 to reach US$ 28.61 Bn by 2026. The global immunoassay market is driven by technological advancements in the development of new immunoassays and analyzers and demographic and life changes favoring rapid, preventive, and predictive diagnosis.
Request Sample of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=19703
An immunoassay is a biochemical test conducted in IVD laboratories for the detection of presence of specific molecules in a solution with the use of an antigen or antibody. Immunoassay diagnostics tests have been widely used for more than 40 years in hospitals, diagnostic laboratories, blood banks, and research laboratories. Immunoassays have a number of applications in in vitro diagnostics for the diagnosis of various chronic as well as infectious diseases, prediction of disease course, framing the treatment, and monitoring the effectiveness of the therapy. Immunoassays are widely used in the life science industry for studying various biological systems by means of analysis of different biological molecules such as proteins, hormones, and antibodies.
High prevalence and rise in incidence rate of chronic and infectious diseases across the globe are projected to be the key drivers of the global immunoassay market during the forecast period.
Read Report Overview: https://www.transparencymarketresearch.com/immunoassay-market.html
Endocrinological diseases such as thyroid dysfunction, diabetes mellitus, osteoporosis, and others are on the rise owing to changing lifestyles. According to the International Diabetes Federation (IDF), in 2015, 415 million people were affected with diabetes worldwide. Various chronic diseases such as chronic respiratory diseases (CRD), diabetes, chronic kidney diseases (CKD), cancer, cardiac stroke, and neurological disorders are leading causes of disability and mortality across the globe. According to the International Agency for Research on Cancer (IARC), more than 14.1 million new cancer cases were diagnosed in 2012, and the global burden is estimated to increase by 21.7 million new cancer cases by the end of 2030. Demographic and lifestyle changes are fueling demand for rapid, preventive, and predictive diagnosis in developed countries. As part of preventive health care, elderly people and people with lifelong diseases such as diabetes, respiratory disorders, and cancer frequently require various medical tests such as blood tests and urine test. Thus, rapidly growing geriatric population across the globe requiring frequent medical tests is likely to be a key driver of the immunoassay market during the forecast period.
Request Brochure of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=19703
Development of integrated systems with complete automation for diagnosis of viral structural changes and new viral epidemics are anticipated to present significant opportunities in the global immunoassay market during the forecast period. With a rise in consolidation among diagnostic laboratories, test volumes are projected to increase. This is expected to boost demand for more integrated multi component systems that can offer solutions such as complete automated sample handling & post process sample storage, data integration with lab automation platform, and remote access monitoring and control. There are few systems available in the market that offer these features. One such system is Siemens Healthineer’s Atellica analyzer system that was introduced in 2016 and received FDA approval in 2017. Recent approvals from the U.S. FDA reflect increasing investments from key players for the development of point-of-care automated immunoassay analyzer systems and the rise in demand from end-users.
Request For Discount On This Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=19703
The global immunoassay market has been segmented based on technology, product, application, end-user, and region. In terms of technology, the global market has been classified into chemiluminescence immunoassay (CLIA), enzyme-linked immunoassay (ELISA), enzyme-linked immunofluorescent assay (ELFA), radioimmunoassay (RIA), and others. The others segment includes microarray, biochip assays, and counting immunoassay. The chemiluminescence immunoassay (CLIA) segment dominated the global market in 2017 and is projected to gain market share by the end of 2026. High sensitivity and lower cost of CLIA are estimated to drive the segment during the forecast period. Moreover, availability of a wide range of assays and high throughput of CLIA analyzers are likely to propel the segment from 2018 to 2026. In terms of product, the global market has been categorized into immunoassay analyzers and consumables. The consumables segment includes immunoassay kits and reagents, calibrators, controls, diluents, buffers, and wash solutions. The consumables segment is estimated to hold around 80% share of the global immunoassay market by the end of 2026.
Based on application, the global immunoassay market has been divided into infectious diseases, endocrinology, oncology, cardiology, orthopedics, and others. The others segment includes autoimmune disorders, therapeutic drug monitoring, gastrointestinal disorders and stool testing, and allergy testing. The infectious disease segment dominated the global immunoassay market in 2017 accounting for more than 25% of the market share. The endocrinology segment is projected to expand at a rapid CAGR during the forecast period.
In terms of end-user, the global immunoassay market has been divided into hospitals & diagnostics laboratories, blood banks, and others. The others segment includes academic and research institutes, pharmaceutical and biotechnology companies, and forensic laboratories. The hospitals & diagnostic laboratories segment accounted for a leading share of the global market and is projected to continue to dominate the market during the forecast period. Rapid increase in the number of health care institutions in emerging countries, large test volume for various diseases, and expansion of laboratory services contributed to the dominant share of the segment in 2017. The blood bank segment held a prominent share of the global immunoassay market in 2017.
Based on region, the global immunoassay market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounted for a dominant share of the global immunoassay market, accounting for more than 35% share in 2017. Europe held a prominent share of the global market in 2017. Well-established health care infrastructure, rapidly increasing geriatric population, and large base of pharmaceutical and biotechnology industries has led to dominant shares of North America and Europe. The market in Asia Pacific is projected to expand at a rapid CAGR during the forecast period owing to rise in foreign direct investment in the health care and life science industry, rapidly increasing number of hospitals and diagnostic laboratories in the region, and large patient population with chronic and infectious diseases.
The global immunoassay market is fragmented, with a large number of companies accounting for majority share in respective regions. Major players operating in the global market include F. Hoffmann-La Roche Ltd., Danaher Corporation, Abbott Laboratories, and Siemens Healthineers. Manufacturers are adopting strategies of mergers and acquisitions with parallel companies to strengthen their product portfolio and geographic reach. Other prominent players operating in the global market include Becton, Dickinson and Company, Ortho Clinical Diagnostics, bioMérieux SA, Sysmex Corporation, and DiaSorin S.p.A.
Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.
Transparency Market Research
90 State Street,
NY - 12207
USA - Canada Toll Free 866-552-3453
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Immunoassay Market to exceed US$ 28.61 Bn by 2026 here
News-ID: 1124149 • Views: 184
More Releases from TMR - Research Reports
Visualization and 3D Rendering Software Market: On-Premise Deployment Presently …
The global market for visualization and 3D rendering features a largely consolidated vendor landscape, with the leading three vendors accounting for a nearly 80% of the overall revenue generated in the market in 2016, observes Transparency Market Research in a recent report. These three vendors, namely Autodesk Inc., Dassault Systems, and NVIDIA Corporation, have strengthened their positions in the market with the help of cost competitive pricing, continuous introduction of
Digital Door Lock Systems Market: Enhanced Security Requirements to Propel the D …
According to a new market report published by Transparency Market Research titled “Digital Door Lock Systems Market–Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026,” the global digital door lock systems market was valued at US$ 1,059.5 Mn in 2017 and is expected to expand at a CAGR of 30.25% from 2018 to 2026, reaching US$ 14,877.6 Mn by the end of the forecast period. digital door lock systems market
Transportation Management System Market: Advance Technologies in All the Sectors …
A transportation management system (TMS) refers to a subset of supply chain management and is centered mostly on logistics and transportation. The augmented use of cloud computing technologies for managing supply chain activities is one of the significant and major trends that have been prevailing in the world market for transportation management systems. Cloud-based deployments, in general, need less configuration and customization. These two factors are triggering down the cost
Energy Recovery Ventilators Market: Rising Awareness of Importance of Indoor Air …
Characterized by the presence of a handful of dominant players, namely United Technologies Corp., LG Electronics, Daikin Industries Ltd., Fujitsu Ltd., and Munters Corp., the global energy recovery ventilators market features intense competition, reveals Transparency Market Research (TMR) in a new report. Going forward, the rising number of players seeking entry will further intensify competition in the market. Expansion of product portfolio which has been the focus of established companies to
More Releases for Immunoassay
Multiplex Detection Immunoassay Market sizes and predictions for growth
MarketResearchReports.Biz adds “Global Multiplex Detection Immunoassay Market Share, Size, Trends and Forecast Market Research Report” reports to its database. This report provides a strategic analysis of the Multiplex Detection Immunoassay and the growth estimates for the forecasted period. This report studies the Multiplex Detection Immunoassay market status and outlook of global and United States, from angles of players, regions, product types and end industries; this report analyzes the top players in
Immunoassay Instruments Market to Witness Widespread Expansion During 2020
A new research report has been recently published by Transparency Market research and is available for sale on the company website. The research report, titled “Immunoassay Instruments Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020”, provides detailed analysis of the global immunoassay instruments market.According to the research study, in 2013, the global market for immunoassay instruments market was worth US$13.5 bn and is anticipated
Automated Immunoassay Analyzers Market Trends, Competitive Analysis, Research Re …
The medical industry report “Automated Immunoassay Analyzers Market Size By Product (Immunofluorescence, Chemiluminescence, ELISA, Enzyme Linked Fluorescent System, Multiplexed Assay System, Radioimmunoassay), By Application (Infectious Diseases, Endocrinology, Drug Monitoring, Cardiology, Oncology, Allergy Testing), By End-use (Hospitals, Diagnostic Laboratories, Research & Academic Laboratories, Pharmaceutical & Biotechnology Companies), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Mexico, South Africa, Saudi Arabia, UAE),
Immunoassay Analyzer Market 2017 to 2022 Euroimmun, BioMerieux, Adaltis, DiaSori …
Immunoassay Analyzer Market 2017 Euroimmun, BioMerieux, Adaltis, DiaSorin. Recently published a detailed market study on the "Immunoassay Analyzer Market" across the global, regional and country level. The report on the global Immunoassay Analyzer market uses the top-down and bottom-up approaches to define, analyze, and describe the Immunoassay Analyzer market trends for the next five years. The Immunoassay Analyzer market report further provides production, capacity, Immunoassay Analyzer market price per region, gross
Immunoassay Systems Market is Expecting Worldwide Growth by 2017 – 2025
Immunoassay has become essential laboratory technique that can be used to measure concentration of different analytes. Immunoassay systems are thus essentially adopted by virtually all the diagnostic laboratories, academic and research institutes, hospital diagnostic centers and other potential end users. Introduction of multiplex immunoassays has further expanded the applications of immunoassay systems in different industries such as pharmaceutical companies, biotechnology and life science industries, food and beverage industries, environment control
Immunoassay Market Size, Share - Industry Growth 2021
Immunoassay Market Size, Capacity, Trends, Outlook, Research, Analysis, Growth | Industry Report 2021 Market Research Report to It’s a Database. Download sample copy @ https://goo.gl/xKYzus The immunoassay market is expected to reach USD 25.45 billion by 2021 from USD 17.16 billion in 2016 at a CAGR of 8.2%. The global immunoassay market is segmented based on product & service, technology, application, enduser, and region. The reagents & kits segment is